Skip to content

Drug interactions

Eluxadoline + Tipranavir

Severity: Moderate

Eluxadoline and Tipranavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tipranavir inhibits hepatic OATP1B1 uptake and raises eluxadoline exposure. Higher levels increase the risk of adverse effects such as constipation, nausea, abdominal pain and pancreatitis.

What this interaction means in plain words

Eluxadoline and Tipranavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eluxadoline belongs to Gastrointestinal Tract; Tipranavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Inhibition of OATP1B1-mediated hepatic uptake of eluxadoline increases systemic concentrations.

What to do

Reduce eluxadoline to 75 mg twice daily during co-administration. Monitor for constipation, abdominal pain and signs of pancreatitis.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eluxadoline and Tipranavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eluxadoline with Tipranavir?

MediHelp rates the interaction as moderate. Eluxadoline and Tipranavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tipranavir inhibits hepatic OATP1B1 uptake and raises eluxadoline exposure. Higher levels increase the risk of adverse effects such as constipation, nausea, abdominal pain and pancreatitis.

How serious is the interaction between Eluxadoline and Tipranavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce eluxadoline to 75 mg twice daily during co-administration. Monitor for constipation, abdominal pain and signs of pancreatitis.

What other medicines interact with Eluxadoline?

MediHelp also lists interactions of Eluxadoline with, for example, Alosetron, Atropine, Buprenorphine. The full list is on the Eluxadoline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in